Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Social Stream
JAZZ PHARMACEUTICALS PLC (JAZZ) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering JAZZ PHARMACEUTICALS PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 15 | $250 | $172 | $204.937 | $128.16 | 59.91% |
| 2021-11-11 | 15 | $250 | $172 | $204.312 | $128.16 | 59.42% |
| 2021-11-16 | 15 | $250 | $172 | $204.125 | $128.16 | 59.27% |
| 2021-12-17 | 14 | $250 | $172 | $203.812 | $128.16 | 59.03% |
| 2021-12-20 | 14 | $250 | $172 | $201.937 | $128.16 | 57.57% |
| 2022-01-06 | 14 | $250 | $172 | $202.312 | $128.16 | 57.86% |
| 2022-01-13 | 14 | $250 | $172 | $202.812 | $128.16 | 58.25% |
| 2022-01-23 | 12 | $250 | $172 | $204.562 | $128.16 | 59.61% |
| 2022-02-11 | 12 | $250 | $172 | $204.437 | $128.16 | 59.52% |
| 2022-02-25 | 11 | $250 | $172 | $202.866 | $128.16 | 58.29% |
| 2022-03-02 | 12 | $250 | $172 | $202.866 | $128.16 | 58.29% |
| 2022-03-04 | 14 | $250 | $172 | $202.266 | $128.16 | 57.82% |
| 2022-03-28 | 14 | $250 | $174 | $203.466 | $128.16 | 58.76% |
| 2022-04-22 | 14 | $250 | $174 | $204.357 | $128.16 | 59.45% |
| 2022-04-28 | 14 | $250 | $174 | $203.785 | $128.16 | 59.01% |
| 2022-05-06 | 14 | $250 | $174 | $205.285 | $128.16 | 60.18% |
| 2022-06-02 | 16 | $250 | $174 | $203.666 | $128.16 | 58.92% |
| 2022-06-14 | 16 | $250 | $174 | $203.062 | $128.16 | 58.44% |
| 2022-08-01 | 15 | $225 | $174 | $199.933 | $128.16 | 56% |
| 2022-09-17 | 16 | $225 | $183 | $200.437 | $128.16 | 56.4% |
| 2022-09-21 | 15 | $225 | $148 | $197.437 | $128.16 | 54.06% |
| 2022-09-29 | 15 | $225 | $170 | $197.312 | $128.16 | 53.96% |
| 2022-10-20 | 14 | $225 | $170 | $196.933 | $128.16 | 53.66% |
| 2022-11-02 | 14 | $225 | $170 | $197.133 | $128.16 | 53.82% |
| 2022-11-30 | 16 | $225 | $180 | $199.437 | $128.16 | 55.62% |
| 2022-12-14 | 16 | $225 | $180 | $199.312 | $128.16 | 55.52% |
| 2023-02-24 | 16 | $225 | $180 | $200.125 | $128.16 | 56.15% |
| 2023-03-06 | 16 | $225 | $180 | $200.25 | $128.16 | 56.25% |
| 2023-04-14 | 16 | $225 | $180 | $201.625 | $128.16 | 57.32% |
| 2023-04-20 | 16 | $225 | $180 | $201.5 | $128.16 | 57.23% |
| 2023-04-24 | 16 | $225.001 | $180 | $201.5 | $128.16 | 57.23% |
| 2023-05-11 | 16 | $225.001 | $180 | $201.312 | $128.16 | 57.08% |
| 2023-05-15 | 16 | $225 | $180 | $201.312 | $128.16 | 57.08% |
The Trend in the Analyst Price Target
Over the past 25 months, JAZZ's average price target has gone down $1.22.
Over the past 50 weeks, JAZZ's average upside potential has been 39.17%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-17 | 16 | 225.000 | 183 | 200.437 | 147.49 | 35.9% |
| 2022-09-29 | 14 | 225.000 | 170 | 198.812 | 132.42 | 50.14% |
| 2022-11-11 | 16 | 225.000 | 180 | 199.437 | 149.15 | 33.72% |
| 2023-04-14 | 16 | 225.000 | 180 | 201.625 | 145.52 | 38.55% |
| 2023-04-24 | 16 | 225.001 | 180 | 201.500 | 144.48 | 39.47% |
JAZZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 13 | 2 | 1 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
JAZZ's average broker recommendation rating worsened by 0.16 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how JAZZ PHARMACEUTICALS PLC fares relative to all US stocks, note that its average analyst price target is greater than 4119.16% of that group.
- JAZZ PHARMACEUTICALS PLC's number of analysts covering the stock is higher than 4067.93% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, JAZZ PHARMACEUTICALS PLC's variance in analysts' estimates is lower than -770.71% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, JAZZ PHARMACEUTICALS PLC's upside potential (average analyst target price relative to current price) is greater than 3347.54% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to JAZZ PHARMACEUTICALS PLC are ALNY, UTHR, and BMRN.
View All Top Stocks by Price Target
Make investment decisions regarding JAZZ using the data that counts. Try POWR Ratings for free.